In this issue

 Oral vancomycin is associated with less therapy intensification in adults with symptomatic inflammatory bowel disease and underlying primary sclerosing cholangitis

Chiraag Kulkarni, Abhishek Dimopoulos-Verma, George Triadafilopoulos, Sidhartha R. Sinha

PDF HTML

 Patterns of prescription and discontinuation of glucagon-like peptide-1 receptor agonists among patients with irritable bowel syndrome

Misha Gautam, Utkarsh Goel, Abbas Bader, Samiya Azim, Noor Hassan, Esmat Sadeddin, Wendell Clarkston, Hassan Ghoz

 

PDF HTML

 Increased capture of post-endoscopic retrograde cholangiopancreatography adverse events by delayed (day 7) follow-up calls: a prospective comparison of physician- and nurse-initiated calls

Monique T. Barakat, Subhas Banerjee

PDFHTML

  Neoadjuvant therapy versus upfront surgery approach in resectable pancreatic cancer: a systematic review and meta-analysis

Caroline Tanadi, Kevin Tandarto, Maureen Miracle Stella, Randy Adiwinata, Jeffry Beta Tenggara, Paulus Simadibrata, Marcellus Simadibrata

PDF HTML


 

Current Issue

Volume 38, No 4 (2025)

Published: 2025-08-04

Table of contents

Review Articles

Original Articles

Letter to the Editor

View All Issues